Literature DB >> 28453853

Single-Molecule Sequencing Revealing the Presence of Distinct JC Polyomavirus Populations in Patients With Progressive Multifocal Leukoencephalopathy.

Hanna Seppälä1, Elina Virtanen1, Mika Saarela2, Pia Laine3, Lars Paulín3, Laura Mannonen1, Petri Auvinen3, Eeva Auvinen1.   

Abstract

Background: Progressive multifocal leukoencephalopathy (PML) is a fatal disease caused by reactivation of JC polyomavirus (JCPyV) in immunosuppressed individuals and lytic infection by neurotropic JCPyV in glial cells. The exact content of neurotropic mutations within individual JCPyV strains has not been studied to our knowledge.
Methods: We exploited the capacity of single-molecule real-time sequencing technology to determine the sequence of complete JCPyV genomes in single reads. The method was used to precisely characterize individual neurotropic JCPyV strains of 3 patients with PML without the bias caused by assembly of short sequence reads.
Results: In the cerebrospinal fluid sample of a 73-year-old woman with rapid PML onset, 3 distinct JCPyV populations could be identified. All viral populations were characterized by rearrangements within the noncoding regulatory region (NCCR) and 1 point mutation, S267L in the VP1 gene, suggestive of neurotropic strains. One patient with PML had a single neurotropic strain with rearranged NCCR, and 1 patient had a single strain with small NCCR alterations. Conclusions: We report here, for the first time, full characterization of individual neurotropic JCPyV strains in the cerebrospinal fluid of patients with PML. It remains to be established whether PML pathogenesis is driven by one or several neurotropic strains in an individual.
© The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.

Entities:  

Keywords:  JCPyV; PML; SMRT; neurotropic; next generation sequencing; polyomavirus

Mesh:

Substances:

Year:  2017        PMID: 28453853     DOI: 10.1093/infdis/jiw399

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  7 in total

Review 1.  Intra-patient viral evolution in polyomavirus-related diseases.

Authors:  Dorian McIlroy; Franck Halary; Céline Bressollette-Bodin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-05-27       Impact factor: 6.237

2.  Progressive multifocal leukoencephalopathy with mild clinical conditions and detection of archetype-like JC virus in cerebrospinal fluid.

Authors:  Kosuke Iwami; Kazuo Nakamichi; Masaaki Matsushima; Azusa Nagai; Shinichi Shirai; Sho Nakakubo; Ikuko Takahashi-Iwata; Masafumi Yamada; Ichiro Yabe
Journal:  J Neurovirol       Date:  2021-09-22       Impact factor: 2.643

Review 3.  Diagnostic and Prognostic Value of MicroRNA in Viral Diseases.

Authors:  Eeva Auvinen
Journal:  Mol Diagn Ther       Date:  2017-02       Impact factor: 4.074

4.  Copy Number Heterogeneity of JC Virus Standards.

Authors:  Alexander L Greninger; Allen C Bateman; Ederlyn E Atienza; Sharon Wendt; Negar Makhsous; Keith R Jerome; Linda Cook
Journal:  J Clin Microbiol       Date:  2016-12-14       Impact factor: 5.948

5.  Exploring the role of NCCR variation on JC polyomavirus expression from dual reporter minicircles.

Authors:  Anne-Sophie L'Honneur; Hervé Leh; Fanny Laurent-Tchenio; Uriel Hazan; Flore Rozenberg; Stéphanie Bury-Moné
Journal:  PLoS One       Date:  2018-06-26       Impact factor: 3.240

6.  Database and Statistical Analyses of Transcription Factor Binding Sites in the Non-Coding Control Region of JC Virus.

Authors:  Kazuo Nakamichi; Toshio Shimokawa
Journal:  Viruses       Date:  2021-11-19       Impact factor: 5.048

7.  Polyomaviruses shedding in stool of patients with hematological disorders: detection analysis and study of the non-coding control region's genetic variability.

Authors:  Carla Prezioso; Marco Ciotti; Francisco Obregon; Donatella Ambroselli; Donatella Maria Rodio; Laura Cudillo; Javid Gaziev; Annamaria Mele; Angelo Nardi; Cartesio Favalli; William Arcese; Anna Teresa Palamara; Valeria Pietropaolo
Journal:  Med Microbiol Immunol       Date:  2019-08-02       Impact factor: 3.402

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.